Consolidated Statements Of Cash Flows - USD ($)	9 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (13,017,508)	$ (6,007,432)	$ (6,938,351)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	452,127	728,459	950,145
Non-cash equity based compensation	287,293	546,288	595,854
Recovery of impaired assets			(585,800)
Loss (gain) on disposal of long-lived assets	39,247
Impairment of inventories	7,166,916	0	9,906
Change in operating assets and liabilities:
Accounts receivable	(681,912)	(140,624)	41,013
Other receivable		855,000	855,000
Costs and estimated earnings on uncompleted contracts	30,379	20,000	(10,379)
Inventories	194,790	351,888	232,706
Prepaid expenses and other current assets	12,915	(32,445)	(6,149)
Accounts payable and other current liabilities	778,615	315,985	(7,463)
Billings in excess of costs and estimated earnings on uncompleted contracts		(24,178)	(84,444)
Other long-term liabilities	(147,222)	(197,802)	(156,135)
Net cash used in operating activities	(4,884,360)	(3,584,861)	(5,104,097)
Cash flows from investing activities:
Acquisition of property and equipment	(47,954)	(59,869)	(144,522)
Cash paid for patent and trademark fees	(18,496)	(29,761)	(32,103)
Net cash used in investing activities	(66,450)	(89,630)	(176,625)
Cash flows from financing activities:
Cash received for shares exercised under employee stock purchase plan	31,347	26,584	39,377
Issuance of common stock in registered direct offering, net of offering costs		5,843,463	5,778,463
Payment of employee tax withholdings in exchange for return of common stock	(10,678)	(92,591)	(92,591)
Net cash provided by financing activities	20,669	5,777,456	5,725,249
(Decrease)/ increase in cash and cash equivalents	(4,930,141)	2,102,965	444,527
Cash and cash equivalents at beginning of period	7,030,230	6,585,703	6,585,703
Cash and cash equivalents at end of period	$ 2,100,089	$ 8,688,668	$ 7,030,230